alk-positive nsclc: cns progression
Published 4 years ago • 77 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
42:31
alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
-
0:39
continuation of ceritinib beyond disease progression in alk-positive nsclc
-
2:34
cns metastasis in alk positive lung cancer
-
2:30
cns disease in alk-positive nsclc: monitoring and systemic vs. radiation therapy
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
1:28:28
alk 101 part 1: i've just been diagnosed with alk positive lung cancer
-
1:15:42
alk 101 part 5: life after lorlatinib
-
10:06
똑똑한 암세포 잡는 표적항암제 총정리 - 연세암병원 종양내과 임선민 교수
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
1:37:00
novel therapies for egfr exon 20 insertions and alk-positive nsclc: developments and implications
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
2:37
crown: lorlatinib in treatment-naïve patients with alk-positive advanced nsclc
-
1:22
assessing the efficacy of alectinib versus crizotinib in alk-positive nsclc
-
6:51
progression in alk nsclc after frontline therapy
-
13:18
nsclc: how to handle alk resistance
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
5:28
crown study: lorlatinib vs crizotinib in 1l nsclc
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer
-
0:44
alk-tkis: targeted therapies for alk-positive nsclc
-
8:11
treating alk-mutated nsclc with disease progression
-
1:02
blood tests for identifying and monitoring alk-positive non-small cell lung cancer
-
4:31
alk-positive nsclc: alex trial